Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript
Vivos Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-3.05 EPS, expectations were $-1.9.
April 1st, 2024 - News Transcripts
June 10th, 2023 - News Transcripts
April 4th, 2023 - News Transcripts
June 15th, 2021 - Hedge Funds News
Returns since its inception in May 2014 (through Feb 16th, 2024)